Oculus up 19% in early trading

Shares of nano cap Oculus Innovative Sciences (OCLS +19.7%) enjoy a pop this morning continuing the up move that began on December 4 when the firm reported the FDA clearance of Microsyn Scar Management HydroGel.

Consensus estimate for Q1 is a loss of $0.19/share on revenues of $3.4M.

Consensus estimates for 2014 and 2015 are a loss of $0.51/share on revenues of $14.2M and a loss of $0.48/share on revenues of $15.2M, respectively.

10 mutual funds have positions, up from 9 a year earlier.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs